NLS Pharmaceutics AG
NLSP0.762USD
0.000
Close 11/04, 16:00（ET）Quotes delayed by 15 min
3.16MMarket Cap
--P/E TTM
More Details of NLS Pharmaceutics AG Company
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
NLS Pharmaceutics AG Info
Ticker SymbolNLSP
Company nameNLS Pharmaceutics AG
IPO dateJan 29, 2021
CEOMr. Alexander Zwyer
Number of employees1
Security typeOrdinary Share
Fiscal year-endJan 29
AddressThe Circle 6
CityZUERICH
Stock exchangeNASDAQ Capital Market Consolidated
CountrySwitzerland
Postal code8058
Phone41445122150
Websitehttps://nlspharma.com/
Ticker SymbolNLSP
IPO dateJan 29, 2021
CEOMr. Alexander Zwyer
Company Executives of NLS Pharmaceutics AG
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
438.17K
+42.03%
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
48.53K
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
12.40K
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
3.00K
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Alexander Zwyer
Mr. Alexander Zwyer
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
438.17K
+42.03%
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
48.53K
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
12.40K
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
3.00K
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Oct 2
Updated: Thu, Oct 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hafner (Ronald)
84.16%
Sarl (League Jann)
39.93%
Revel (Michel)
36.30%
Alpha Capital Aktiengesellschaft
30.98%
BVF Partners L.P.
27.59%
Shareholders
Shareholders
Proportion
Hafner (Ronald)
84.16%
Sarl (League Jann)
39.93%
Revel (Michel)
36.30%
Alpha Capital Aktiengesellschaft
30.98%
BVF Partners L.P.
27.59%
Shareholder Types
Shareholders
Proportion
Individual Investor
193.29%
Holding Company
30.98%
Hedge Fund
27.59%
Investment Advisor
14.84%
Research Firm
0.48%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
18
223.48K
4.90%
-129.02K
2025Q2
26
1.40M
38.90%
+507.92K
2025Q1
22
894.91K
48.25%
+498.74K
2024Q4
29
1.02M
51.68%
+526.99K
2024Q3
29
831.36K
56.13%
+285.14K
2024Q2
30
615.17K
76.38%
+216.04K
2024Q1
28
605.94K
63.12%
+266.33K
2023Q4
27
460.27K
50.03%
+88.87K
2023Q3
27
471.85K
51.33%
+97.30K
2023Q2
26
476.03K
51.79%
+104.44K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hafner (Ronald)
438.17K
8.93%
+129.67K
+42.03%
May 22, 2025
Sarl (League Jann)
207.91K
4.24%
+207.91K
--
May 15, 2025
Revel (Michel)
189.01K
3.85%
+189.01K
--
May 15, 2025
Alpha Capital Aktiengesellschaft
161.29K
3.29%
-85.71K
-34.70%
May 15, 2025
BVF Partners L.P.
143.68K
2.93%
--
--
Jun 30, 2025
Grisard (Felix)
107.37K
2.19%
+107.37K
--
Oct 15, 2024
The Lind Partners, LLC
59.78K
1.22%
-43.75K
-42.26%
Dec 31, 2024
Konofal (Eric)
48.53K
0.99%
+48.53K
--
May 15, 2025
UBS Financial Services, Inc.
14.98K
0.31%
-10.76K
-41.79%
Jun 30, 2025
Rinaldi (Gian-Marco)
12.40K
0.25%
+12.40K
--
May 15, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Date
Type
Ratio
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
